GL1X · GenesisL1 explorer

MolNFT v1 · #9417 · protein

Structural basis of drug resistance for the V82A mutant of HIV-1 protease: backbone flexibility and subsite repacking

1HVS: “Structural basis of drug resistance for the V82A mutant of HIV-1 protease: backbone flexibility and subsite…”. X-ray diffraction, 1 ligand (A77), 1 pocket (best druggability 0.69). MolNFT v1 #9417 on GenesisL1: 3D structure, binding…

PDB
1HVS
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
UniProt
P04587
Ligands
A77
Pockets
1 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHIV-1 proteaseprotein994% helix, 56% strandP04587

Ligands and binding sites

  • A77 · N-{1-benzyl-(2R,3S)-2,3-dihydroxy-4-[3-methyl-2-(3-methyl-3-pyridin-2-ylmethyl-ureido)-butyrylamino]-5-phenyl-pentyl}-3-methyl-2-(3-methyl-3-pyridin-2-ylmethyl-ureido)-butyramide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14360.690.8040A77

Interfaces

1 interface between chains.

  • A–B · 1835 Ų buried · 40 hydrogen bonds · protein-protein

Compared structures

  • 1HVS · Structural basis of drug resistance for the V82A mutant of HIV-1 protease: backbone… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.